Predictors of Risk and Success of Obesity Surgery.


Journal

Obesity facts
ISSN: 1662-4033
Titre abrégé: Obes Facts
Pays: Switzerland
ID NLM: 101469429

Informations de publication

Date de publication:
2019
Historique:
received: 05 10 2018
accepted: 14 01 2019
pubmed: 16 8 2019
medline: 12 2 2020
entrez: 16 8 2019
Statut: ppublish

Résumé

Obesity surgery has proven successful for weight loss and the resolution of comorbidities. There is, however, little evidence on its success and the risk of complications when considering age of onset of obesity (AOO), years of obesity (YOO), preoperative body mass index (BMI), Edmonton obesity staging system (EOSS) score, and age as possible predictors of weight loss, the resolution of comorbidities, and the risk of complications. Patients who underwent Roux-en-Y gastric bypass (RYGB) and laparoscopic sleeve gastrectomy (LSG) from a prospective database were analyzed. Multiple regression analyses were used to predict comorbidities and their resolution, percentage excess weight loss (%EWL) and total weight loss (%TWL) 12 months after surgery, and the risk of complications using the predictors AOO, YOO, age, EOSS, and BMI. 180 patients aged 46.8 ± 11.1 years with a preoperative BMI 49.5 ± 7.5 were included. The number of preoperative comorbidities was higher with older age (β = 0.054; p = 0.023) and a greater BMI (β = 0.040; p = 0.036) but was not related to AOO and YOO. Patients with AOO as a child or adolescent were more likely to have an EOSS score of ≥2. Greater preoperative BMI was negatively associated with %EWL (β = -1.236; p < 0.001) and older age was negatively associated with %TWL (β = -0.344; p = 0.020). Postoperative complications were positively associated with EOSS score (odds ratio [OR] 1.147; p = 0.042) and BMI (OR 1.010; p = 0.020), but not with age. AOO and YOO were not related to postoperative outcome. Greater BMI was associated with a lower %EWL and age was associated with a low %TWL. YOO and AOO did not influence outcome. Age, BMI, and EOSS score were the most important predictors for risk and success after obesity surgery. Surgery should be performed early enough for optimal outcomes.

Sections du résumé

BACKGROUND
Obesity surgery has proven successful for weight loss and the resolution of comorbidities. There is, however, little evidence on its success and the risk of complications when considering age of onset of obesity (AOO), years of obesity (YOO), preoperative body mass index (BMI), Edmonton obesity staging system (EOSS) score, and age as possible predictors of weight loss, the resolution of comorbidities, and the risk of complications.
METHODS
Patients who underwent Roux-en-Y gastric bypass (RYGB) and laparoscopic sleeve gastrectomy (LSG) from a prospective database were analyzed. Multiple regression analyses were used to predict comorbidities and their resolution, percentage excess weight loss (%EWL) and total weight loss (%TWL) 12 months after surgery, and the risk of complications using the predictors AOO, YOO, age, EOSS, and BMI.
RESULTS
180 patients aged 46.8 ± 11.1 years with a preoperative BMI 49.5 ± 7.5 were included. The number of preoperative comorbidities was higher with older age (β = 0.054; p = 0.023) and a greater BMI (β = 0.040; p = 0.036) but was not related to AOO and YOO. Patients with AOO as a child or adolescent were more likely to have an EOSS score of ≥2. Greater preoperative BMI was negatively associated with %EWL (β = -1.236; p < 0.001) and older age was negatively associated with %TWL (β = -0.344; p = 0.020). Postoperative complications were positively associated with EOSS score (odds ratio [OR] 1.147; p = 0.042) and BMI (OR 1.010; p = 0.020), but not with age. AOO and YOO were not related to postoperative outcome.
CONCLUSION
Greater BMI was associated with a lower %EWL and age was associated with a low %TWL. YOO and AOO did not influence outcome. Age, BMI, and EOSS score were the most important predictors for risk and success after obesity surgery. Surgery should be performed early enough for optimal outcomes.

Identifiants

pubmed: 31416073
pii: 000496939
doi: 10.1159/000496939
pmc: PMC6758709
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

427-439

Informations de copyright

© 2019 The Author(s) Published by S. Karger AG, Basel.

Références

Obes Surg. 2015 Feb;25(2):254-62
pubmed: 25085223
Surg Obes Relat Dis. 2008 Sep-Oct;4(5 Suppl):S73-108
pubmed: 18490202
Surg Endosc. 2006 Jun;20(6):859-63
pubmed: 16738970
JAMA. 2010 Jul 28;304(4):435-42
pubmed: 20664044
Surg Obes Relat Dis. 2011 Nov-Dec;7(6):691-6
pubmed: 20688578
Surg Obes Relat Dis. 2014 May-Jun;10(3):516-23
pubmed: 24951069
Ann Intern Med. 2005 Apr 5;142(7):547-59
pubmed: 15809466
Surg Obes Relat Dis. 2010 Jul-Aug;6(4):451-60
pubmed: 20570572
Obesity (Silver Spring). 2015 Feb;23(2):443-7
pubmed: 25451850
Obes Surg. 2009 Jun;19(6):732-7
pubmed: 19277799
Surg Endosc. 2012 Jun;26(6):1744-50
pubmed: 22234587
Surg Obes Relat Dis. 2009 May-Jun;5(3):387-405
pubmed: 19460678
J Pediatr. 2007 Jan;150(1):12-17.e2
pubmed: 17188605
Gut. 2000 Jul;47(1):26-9
pubmed: 10861260
Surg Endosc. 2013 Apr;27(4):1273-80
pubmed: 23239292
Obes Surg. 2017 Jun;27(6):1446-1452
pubmed: 27943095
J Pediatr Surg. 2016 May;51(5):853-8
pubmed: 27261561
Obes Surg. 2006 Sep;16(9):1227-31
pubmed: 16989709
Ann Surg. 2007 Dec;246(6):1034-9
pubmed: 18043107
BMC Public Health. 2009 Mar 25;9:88
pubmed: 19320986
Chirurg. 2014 Apr;85(4):334-41
pubmed: 23954906
Arch Surg. 2007 Oct;142(10):969-75; discussion 976
pubmed: 17938311
Obes Rev. 2008 Sep;9(5):474-88
pubmed: 18331423
Obes Surg. 2007 Dec;17(12):1608-13
pubmed: 18030543
Int J Obes (Lond). 2007 Apr;31(4):569-77
pubmed: 17325689
Obes Surg. 2010 Mar;20(3):276-82
pubmed: 19636644
Neurogastroenterol Motil. 2006 Nov;18(11):987-94
pubmed: 17040409
Obes Surg. 2006 Dec;16(12):1609-14
pubmed: 17217637
Obes Surg. 2013 Mar;23(3):292-9
pubmed: 23196992
Pediatr Obes. 2012 Aug;7(4):261-73
pubmed: 22461384
Obes Surg. 2017 Jun;27(6):1453-1459
pubmed: 27943093
Ann Surg. 2002 Nov;236(5):576-82
pubmed: 12409663
Postgrad Med. 2009 Nov;121(6):21-33
pubmed: 19940414
Surg Endosc. 2003 Apr;17(4):603-9
pubmed: 12582767
Ann Surg. 2003 Jun;237(6):751-6; discussion 757-8
pubmed: 12796570
Obes Surg. 2006 Apr;16(4):478-83
pubmed: 16608614
Obes Surg. 2000 Jun;10(3):233-9
pubmed: 10929154
Surg Obes Relat Dis. 2012 Nov-Dec;8(6):671-7
pubmed: 23058451
Obes Surg. 2015 May;25(5):782-7
pubmed: 25361763
Obes Surg. 2017 Jun;27(6):1414-1422
pubmed: 28035521
Arch Surg. 2006 Mar;141(3):262-8
pubmed: 16549691
Ann Surg. 2013 Nov;258(5):760-5; discussion 765-6
pubmed: 23979278
JAMA. 2012 Feb 1;307(5):483-90
pubmed: 22253364
N Engl J Med. 2004 Dec 23;351(26):2683-93
pubmed: 15616203
Obes Surg. 2017 Jul;27(7):1684-1690
pubmed: 28058616
Obes Surg. 2007 Sep;17(9):1235-41
pubmed: 18074500
Surg Obes Relat Dis. 2017 Feb;13(2):313-319
pubmed: 28029597
Int J Obes (Lond). 2009 Mar;33(3):289-95
pubmed: 19188927
Obes Surg. 2011 Feb;21(2):212-6
pubmed: 20835778
Surg Obes Relat Dis. 2014 Jul-Aug;10(4):661-5
pubmed: 24582415
BMC Surg. 2015 Jul 18;15:87
pubmed: 26187377
Obesity (Silver Spring). 2007 Apr;15(4):929-38
pubmed: 17426328
Obes Surg. 2011 Dec;21(12):1947-9
pubmed: 22002510
Obes Surg. 2016 Aug;26(8):1867-74
pubmed: 26660688
Am J Gastroenterol. 2005 Jun;100(6):1243-50
pubmed: 15929752
Clin Dermatol. 2004 Jul-Aug;22(4):276-80
pubmed: 15475226
Am J Epidemiol. 1999 Feb 1;149(3):256-60
pubmed: 9927221
Obes Surg. 2017 Jun;27(6):1508-1513
pubmed: 28050788
Obes Surg. 2017 May;27(5):1292-1297
pubmed: 27878423
Obes Surg. 2013 Sep;23(9):1445-9
pubmed: 23733390
Surg Obes Relat Dis. 2016 Dec;12(10):1847-1855
pubmed: 27317606

Auteurs

Felix Nickel (F)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.

Javier R de la Garza (JR)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.

Fabian S Werthmann (FS)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.

Laura Benner (L)

Institute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany.

Christian Tapking (C)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.

Emir Karadza (E)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.

Anna-Laura Wekerle (AL)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.

Adrian T Billeter (AT)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.

Hannes G Kenngott (HG)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.

Lars Fischer (L)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.

Beat Peter Müller-Stich (BP)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany, Beatpeter.Mueller@med.uni-heidelberg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH